- Français -  
Home     Services     New Treatments     Team      Contact Us    

Memory Clinic with interest in early onset dementia

Alzheimer’s disease is the most common cause of age associated cognitive decline worldwide. It is estimated that more people will be affected by this condition, due to the increasing longevity of our population.

Our Clinic’s primary focus is Evaluation to provide treatments – both symptomatic and preventive - to ensure long-term stabilization for patients and to enhance the quality of life for patients and caregivers.

The Memory Clinic of the Alzheimer Disease Research Unit, a division of the McGill University Research Centre for Studies in Aging, under the Faculty of Medicine of McGill University, was founded in 1997 to establish a clinic that specializes in memory loss caused by Alzheimer’s disease and related disorders.


Memory decline can be part of the normal aging process but may also be due to other causes such as; sleep apnea, depression and medication side effects.

The memory clinic utilizes the best clinical practices and cutting-edge technologies for diagnosis of medical conditions associated with memory problems. A cognitive assessment

In fact, our clinic collaborates with other experts at McGill University to provide the most advanced and sensitive Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET) protocols for evaluating patients with mild cognitive complaints. The PET and MRI technology combined with the clinical expertise, allow for a very early diagnosis and appropriate treatment of the condition causing the underlying memory deficits.

The memory clinic evaluation includes diagnosis, treatment, follow-up and referral to medical and community resources for support.


Dr. Serge Gauthier, MD, FRCPC, neurologist and Director of the Alzheimer Disease Research Unit, is a specialist in the field and leads a team of experienced and dedicated professionals (doctors, neuropsychologists, nurses, researchers). He is the founder of the Canadian Consortium for Clinical Cognitive Research (C5R) which has 32 accredited research sites across Canada.

The memory clinic is actively involved in research for new therapies and is an internationally recognized clinical trial site. The clinic has participated in more than 40 multi-centre trials world-wide including the studies that lead to the marketed treatments currently available. Studies (Phases II-IV) that test the efficacy and safety of experimental drugs are ongoing.